Articles
- EU Regulatory: Giant Pharmaceuticals Are Fined Again for Disorganizing Market
- Scientists Identified the Role of Osteopontin for Mesenchymal Stem Cells
- A Novel Biomarker for Metabolic Dysfunction and New Hope for Obesity—Protein PAR2
- Creative BioMart “Morning Talk”: Give Answers to Diagnostic Enzymes
- Hybridoma Offers a Powerful Solution for Monoclonal Antibodies
- Broader Portfolio of Recombinant Antibodies Launched by Creative BioMart
- Does Immune Response Depend on the Solar Cycle?
- Creative BioMart Updates New Product—Thrombin
- Learn More about Protein Structure Evolution with “Ancient” Proteins
- Retrospective Viewpoint: Biotechnology Companies Keep Going with Mergers
- Biomolecular Finding: New Toxic-antitoxic System May Help to Inspire New Antibiotics
- Worldwide BiotechBiopharma Alliance within the Two Days
- A Potential Way to Measure Injury with the Help of Protein Xin
- Opinion: A Summary of Antibody-drug Conjugates
- Tips for Choosing Antibodies at Creative BioMart
- New ALK Recombinant Protein Products Are Launched by Creative BioMart
- Things You May Would Like to Know about Recombinant Antibodies
- A Summary of Characteristics of the Bio-pharmaceutical Industry
- Scientists Successfully Decode the Structure of Protein LIMP-2
- What Quality Collaboration Brings for Technology Transfer?
- Nature Reports Reveal that MX2 is Also a Powerful Inhibitor for HIV-1
- Cleveland Clinic Published Its Selection of Top Three “Groundbreaking” Pharmaceutics
- New Finding on Recombinant Human Prion Protein
- Discussion: Will Google Invest Bio-pharmaceuticals after Its Health-care Part